Restorelle 522 Study

Currently, CARE is proud to be involved in a major international multicentre research project Restorelle ® Transvaginal Mesh versus native Tissue Repair for Treatment of Pelvic Organ Prolapse, Restorelle 522 Study.  

Information regarding this project is available at https://clinicaltrials.gov/ct2/show/NCT02162615. This project has ethics approval from St. Vincent’s Hospital HREC with reference Number HREC/16/SVH/304.

Research

Advances and Controversies in Pelvic Organ Prolapse Surgery

Pelvic organ prolapse , a term referring to the herniation of one or more of the pelvic organs (bladder, uterus, small bowels, rectum) through the vaginal walls and eventual protrusion outside the vagina, is seen in up to 50% of parous women, of whom 20% may develop symptoms and 11% may require surgery (Olsen 1997). Apart from a bulge protruding

Read More